Greater China Sector Updates | Consumer In 2Q25/1H25, among 22 companies under our coverage, 9 beat / 7 inline or mixed / 6 missed. We observed: a) Deflation persists. b) Companies with more diversified product portfolios, along with product offerings ridding on the emerging consumption trends, stay constructive. c) Companies are expanding into new consumption channels. d) Sectors supported by monetised policy stimulus continue to demonstrate robust domestic sales in 3Q25. e) Companies are c...
• The influx of safe haven liquidity could be structural and persistent, thus continuing to exert downward pressure on banks’ NIM. • We expect the Fed to cut the Fed Funds Rate four times totalling 100bp, bringing it to 3.25%. • Downgrade to MARKET WEIGHT. BUY OCBC (Target: S$20.40). HOLD DBS (Target: S$54.40).
Greater China Initiation Coverage | Metasurface Technologies Holdings (8637 HK/BUY/HK1.48/Target: HK2.90) Metasurface is set to benefit from robust investment in the semi supply chain. As chip fabrication grows in complexity, more time is required to fabricate wafers and more wafer fabrication equipment is needed. Aerospace engineering is set to drive long-term growth as airline capacity continues to face shortages, forcing airlines to rely on their existing fleets and bo...
Attractive yield differentials. With Singapore government bond yields trending lower, the yield differential between fixed income and equities has narrowed in 2025, thus reinforcing the relative appeal of companies offering high, sustainable dividend payouts. Equity yields in the 4-6% range now offer a compelling pickup versus the 10-year Singapore Government Bond yield (1.8579% as at 4 Sep 25), while also providing potential for capital gains. In our view, this widening yield gap should support...
GREATER CHINA Strategy Alpha Picks: September Conviction Calls: Add Anta, BYDE and CSCEC to our BUY list, Li Auto and OOIL to our SELL list. Take profit on Innovent, JD Logistics, Lenovo, Sino Biopharm, Tencent and TME. INDONESIA Strategy Alpha Picks: Underperformance In August: Our new Alpha Picks are ASSA, ARCI, BBCA, BBNI, BRMS, MTEL, HRUM and NCKL. MALAYSIA Strategy Alpha Picks: Wake Me Up When September Ends: Our Aug 25 Alpha Picks underperformed marginally. Sep 25 picks: Alpha IVF, Hume ...
Our Alpha Picks portfolio delivered another month of strong performance, rising 11.4% mom in Aug 25 to overwhelm the STI’s 2.3% gain. On a market cap-weighted basis, the portfolio gained 3.2% mom, also ahead of the benchmark by 0.9ppt. For Sep 25, we add BRC for its construction exposure and YZJSGD for its new order flow and inexpensive valuations, while locking in gains on CICT, CD and PROP.
KEY HIGHLIGHTS Strategy Alpha Picks: Double Happiness Again In Aug 25 Our Alpha Picks portfolio rose 11.4% mom in Aug 25, overwhelming the STI’s 2.3% gain. Add BRC, YZJSGD; remove CICT, CD, PROP. TRADERS' CORNER First Resources (FR SP): Trading BUY Singapore Exchange (SGX SP): Trading SELL
Singapore’s 1H25 results season was resilient, with 75% of companies meeting or beating expectations despite tariff uncertainty and strength of the Singapore dollar. Banks delivered stable earnings and attractive yields, underpinning the STI. Consumer names like DFI and SSG stood out, while REITs showed positive rental reversions. Capital recycling drove upgrades for CIT and VMS. We raise our end-25 STI target to 4,602, reflecting 8% upside and attractive valuations versus history and peers.
GREATER CHINA Results CSPC Pharmaceutical Group (1093 HK/BUY/HK$10.51/Target: HK$12.00) 1H25: Results miss; expects hoh sales recovery and two more BD deals in 2H25. Ganfeng Lithium (1772 HK/BUY/HK$30.80/Target: HK$40.00) 2Q25: Net loss in line; 3Q25 turnaround on the back of lithium carbonate price recovery. Maintain BUY, target price: HK$40.00. Li Ning (2331 HK/HOLD/HK$19.70/Target: HK$18.90) 1H25: Results beat but challenges remain in 2H25; fa...
Strategy Results Roundup 1H25 results roundup: A resilient earnings season with banks carrying the load, REITs upping rents. Raising STI target to 4,602. Sector REITs Jackson Symposium provides turnaround momentum. TRADERS' CORNER Singapore Telecommunications (ST SP): Trading BUY First Resourc...
GREATER CHINA Economics Inflation Deflationary pressures persist despite core CPI resilience. INDONESIA Update Darma Henwa (DEWA IJ/BUY/Rp222/Target: Rp372) Sustaining the growth momentum. MALAYSIA Update Uzma (UZMA MK/BUY/RM0.41/Target: RM0.76) Aggressive orderbook growth driven by O&G. However, its five-year recurring income target will miss, due to del...
Banks delivered resilient earnings in 2Q25 (DBS: +0.7% qoq, OCBC: -6.6% qoq) despite severe NIM compression. The downdraft from NIM compression should moderate in 2H25. Asset quality remains relatively stable, unruffled by uncertainties from reciprocal tariffs. Banks provide an attractive dividend yield of 5.9% for 2025. BUY OCBC (Target: S$20.15) for its low 2025F P/B of 1.26x. HOLD DBS (Target: S$52.80) for its 2025 yield of 6.9%. Maintain OVERWEIGHT.
GREATER CHINA Strategy Alpha Picks: August Conviction Calls: Add JBM Healthcare and Lenovo to our BUY list. Take profit on CATL, Han’s Laser, KE Holdings and Longfor. INDONESIA Strategy Alpha Picks: Underperformance In July: Our new Alpha Picks are ASSA, AKRA, ARCI, BBNI, KLBF, MTEL, and MYOR. MALAYSIA Strategy Alpha Picks: Some Opportunities Amid A “Summer Lull”: Our July 25 Alpha Picks outperformed. Aug 25 picks: Coraza, Eco World, Gamuda, Hume Cement, IJM, Inari, RHB and Zetrix. SINGAPORE ...
OCBC reported a net profit of S$1,767m in 2Q25 (-7% yoy), supported by growth in non-interest income (fee income: +24% yoy and net trading income: +6% yoy). NIM compressed by a severe 28bp yoy and 12bp qoq due to a steep drop in SORA and HIBOR. Asset quality was largely benign. Management remains committed to its capital management plan to return S$2.5b to shareholders. OCBC provides a dividend yield of 5.8% for 2025. Maintain BUY. Target price: S$20.15.
Despite the STI hitting record highs in Jul 25, our Alpha Picks portfolio managed to pull off a massive beat, increasing 17.7% mom on an equal-weighted basis and surpassing the STI by 12.4ppt. Also, on a market cap-weighted basis, our Alpha Picks portfolio grew steadily by 6.0% mom, still beating the STI by a decent 0.7ppt. For Aug 25, we add HLA, MPM and CSE while removing IFAST and SSG.
GREATER CHINA Sector Macau Gaming: Jul 25 GGR beat consensus by 5%, hitting post-pandemic high; raise full-year GGR forecast to 7% yoy growth. Results Xinyi Solar Holdings (968 HK/BUY/HK$3.09/Target: HK$3.60): 1H25: Results in line. Policy boost and supply discipline drive re-rating potential; upgrade to BUY. Update Plover Bay Technologies (1523 HK/BUY/HK$6.91/Target: HK$7.83): Takeaways from luncheon: Growing the Peplink ecosystem. INDONESIA Strategy Alpha Picks: Underperformance In July: Our ...
KEY HIGHLIGHTS Strategy Alpha Picks: Massive Outperformance For Jul 25 Our Alpha Picks portfolio surpassed the STI by a massive 12.4ppt in Jul 25. Add HLA, MPM and CSE; remove IFAST and SSG. Results Mapletree Pan Asia Commercial Trust (MPACT SP/BUY/S$1.28/Target: S$1.86) 1QFY26: Lower operating and interest expenses offset overseas headwinds. NetLink NBN Trust (NETLINK SP/BUY/S$0.895/Target: S$0.98) 1QFY26: Muted result...
KEY HIGHLIGHTS Strategy Small-Mid Cap Small mid cap stocks are biggest beneficiaries of MAS’ S$1.1b distribution. Sector Banking Higher reciprocal tariffs could further delay rate cuts. Results SIA Engineering (SIE SP/HOLD/S$3.35/Target: S$3.41) 1QFY26: Earnings beat thanks to strong JV/associate contributions; SIAEC appears fairly valued after recent share price surge. Downgrade to HOLD. TRADERS' CORNER SIA Engineering Co (SIE SP): Trading BUY ...
Higher reciprocal tariffs, ranging from 25% for Japan to 50% for Brazil, would kick in starting 1 August, which could feed into higher inflation in the near term. A subservient next Fed chair sympathetic to Trump’s preference for low interest rates could lead to structurally higher inflation over the long term. Banks could weather volatility from the trade conflict as higher inflation could lead to delays in rate cuts. Maintain OVERWEIGHT. BUY OCBC (Target: S$19.25). HOLD DBS (Target: S$47.00).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.